Cue Biopharma, Inc. (CUE) Financials

CUE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 30.7 million 28.4 million
March 31, 2026 30.9 million 9.3 million
Dec. 31, 2025 42.2 million 15.8 million
Sept. 30, 2025 31.6 million 18.4 million

CUE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -29.0 million 23.8 million
March 31, 2026 -11.1 million 48000
Dec. 31, 2025 -1.1 million 610000
Sept. 30, 2025 -9.0 million 1.5 million

CUE Net Income

No data available :(

CUE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 17.4 million - 3.1 million
March 31, 2026 16.4 million - 3.4 million
Dec. 31, 2025 27.1 million - 4.2 million
Sept. 30, 2025 18.7 million - 4.7 million

CUE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 6.3 million
March 31, 2026 4.8 million
Dec. 31, 2025 3.7 million
Sept. 30, 2025 3.4 million

CUE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 49.0 million 46.6 million -
March 31, 2026 121000 6.9 million 4.2 million -
Dec. 31, 2025 - 16.5 million 3.5 million -
Sept. 30, 2025 - 4.7 million 4.9 million -

CUE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.9 million 36000
March 31, 2026 5.7 million 77000
Dec. 31, 2025 21.9 million 3.2 million
Sept. 30, 2025 2.1 million 79000

CUE

Price: $16.71

52 week price:
4.97
45.50

Earnings Per Share: -28.42 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 255300

Market Capitalization: 168.1 million

Links: